In addition, a BRCA1-mutation is associated with the more aggressive molecular phenotype of FBC (e.g., triple receptor–negative, oestrogen receptor (ER) negative, progesterone receptor (PR) negative, and HER2 negative), earlier disease onset, and family history of breast cancer [45]. The gene discussed is PGR; the disease is breast carcinoma.